Cowen And Company, LLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Cowen And Company, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $261,464 - $341,138	9,800 Added 48.51%	30,000 $24,000
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $597,516 - $1.01 Million	20,200 New	20,200 $40,000
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $2.85 Million - $3.96 Million	-68,100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$52.06 - $61.27 $2.46 Million - $2.89 Million	47,200 Added 225.84%	68,100 $155,000
Q1 2021 May 04, 2021	BUY	$44.23 - $57.5 $482,106 - $626,750	10,900 Added 109.0%	20,900 $137,000
Q4 2020 Feb 08, 2021	BUY	$33.21 - $46.54 $332,100 - $465,400	10,000 New	10,000 $63,000
Q1 2020 May 11, 2020	SELL	$31.52 - $53.81 $157,600 - $269,050	-5,000 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$30.08 - $50.59 $150,400 - $252,950	5,000 New	5,000 $42,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.